Marex Group’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Marex Group’s Portfolio PSTX Stock Details PSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-118,161	Closed	-$1.13M	–	893
2024 Q4	$1.13M	Hold	118,161	–	–	0.02%	225
2024 Q3	$338K	Hold	118,161	–	–	0.01%	361
2024 Q2	$345K	Hold	118,161	–	–	0.01%	383
2024 Q1	$377K	Hold	118,161	–	–	0.01%	297
2023 Q4	$397K	Buy	+118,161	New	+$304K	0.02%	342

Other funds holding PSTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Marex Group's PSTX Position: Q1 2025 in Review

Marex Group sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 118,161 shares — an estimated $1.13M sold.

Marex Group first reported a position in PSTX in Q4 2023 and held it in 5 quarters. The position peaked at $1.13M in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

Marex Group reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Marex Group sold 118,161 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $1.13M.
Marex Group first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2023 and held it in 5 quarters.
Marex Group's Poseida Therapeutics, Inc. Common Stock position peaked at $1.13M in Q4 2024.
1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Marex Group's 13F filing for Q1 2025, filed 2 Apr 2026.